Old Web
English
Sign In
Acemap
>
Paper
>
URINASTATIN VERSUS NAFAMOSTAT MESYLATE IN THE PREVENTION OF POST-ERCP PANCREATITIS
URINASTATIN VERSUS NAFAMOSTAT MESYLATE IN THE PREVENTION OF POST-ERCP PANCREATITIS
2020
Jungrae Lee
Dukjin Kang
Hyoung-Woo Kim
SB Park
Su Jae Kim
HS Nam
Keywords:
Nafamostat mesylate
Internal medicine
Urinastatin
Gastroenterology
post ercp pancreatitis
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]